- Home
- VLY vs AXSM Comparison
VLY vs AXSM Comparison
Compare VLY & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- AXSM
- Stock Information
- Founded
- VLY 1927
- AXSM 2012
- Country
- VLY United States
- AXSM United States
- Employees
- VLY N/A
- AXSM N/A
- Industry
- VLY Major Banks
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- VLY Finance
- AXSM Health Care
- Exchange
- VLY Nasdaq
- AXSM Nasdaq
- Market Cap
- VLY 5.2B
- AXSM 5.9B
- IPO Year
- VLY N/A
- AXSM 2015
- Fundamental
- Price
- VLY $10.93
- AXSM $135.69
- Analyst Decision
- VLY Buy
- AXSM Strong Buy
- Analyst Count
- VLY 15
- AXSM 20
- Target Price
- VLY $12.80
- AXSM $176.70
- AVG Volume (30 Days)
- VLY 15.4M
- AXSM 529.5K
- Earning Date
- VLY 10-23-2025
- AXSM 11-03-2025
- Dividend Yield
- VLY 4.03%
- AXSM N/A
- EPS Growth
- VLY 40.78
- AXSM N/A
- EPS
- VLY 0.88
- AXSM N/A
- Revenue
- VLY $1,704,193,000.00
- AXSM $561,263,000.00
- Revenue This Year
- VLY $33.72
- AXSM $63.66
- Revenue Next Year
- VLY $10.10
- AXSM $54.46
- P/E Ratio
- VLY $12.43
- AXSM N/A
- Revenue Growth
- VLY 8.06
- AXSM 65.83
- 52 Week Low
- VLY $7.48
- AXSM $75.56
- 52 Week High
- VLY $11.35
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- VLY 55.26
- AXSM 66.65
- Support Level
- VLY $10.67
- AXSM $123.50
- Resistance Level
- VLY $10.93
- AXSM $137.70
- Average True Range (ATR)
- VLY 0.35
- AXSM 5.09
- MACD
- VLY 0.03
- AXSM 0.24
- Stochastic Oscillator
- VLY 74.39
- AXSM 85.85
About VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.